Moderna Inc.

Range dropdown markets

Sectors
Nasdaq

Volume: 2.69M 65-Day Average: 4.19M

64% vs Average 146.90 Days Range 153.76, 115.03 52-Week Range 217.25

Partner Center

Your Watchlists

Recent Viewed Tickers

Key Data

% of Float Shorted 4.677%
Average Volume 4.19M

Performance

5 Days

-0.40%

1 Month

7.30%

3 Months

-24.94%

YTD

-16.81%

1 Year

-9.94%

Analyst Ratings

Buy

Ratings: 21 Ratings

MarketWatch Dow Jones

Moderna Inc. stock rises Thursday, still underperforms market

Mar. ET by MarketWatch Automation

Generation Bio, Moderna announce collaboration

Mar. ET by Jaimy Le

Generation Bio shares rise 19% thanks to Moderna Strategic Collaboration

Mar. ET

Generation Bio and Moderna Join Collaboration to Accelerate Nonviral Genetic-Medicines Pipeline

Mar. ET

Moderna Inc. stock performs poorly Wednesday compared to its competitors

Mar. ET by MarketWatch Automation

Moderna CEO defends Congress price hike for COVID vaccine

Mar. ET by Jaimy Le

Senate grills Biotech and Pharma Moderna CEOs on Price of Covid-19 Vaccine

Mar. ET by Barron's

China allows first homegrown mRNA COVID vaccine to be used in an emergency: WSJ

Mar. ET by Ciara Linnane

Markets: The Bank Turmoil isn't Over. The Fed Looking Forward: What it Means.

Mar. ET

Moderna Inc. stock falls Tuesday, underperforms market

Mar. ET by MarketWatch Automation

Moderna Inc. stock rises Monday, outperforms market

Mar. ET by MarketWatch Automation

Moderna Inc. stock performs poorly Friday compared to its competitors

Mar. ET by MarketWatch Automation

How a nasal vaccination could lower the risk of COVID infection -- and how it can be modified

Mar. ET by Jaimy Le

Moderna Inc. stock rises Thursday, still underperforms market

Mar. 16, 2023 at 4 :31 p.m. ET by MarketWatch Automation

Moderna is boosted by expansion plans. However, SVB fallout continues pressure on banks and financials

Mar. ET by Ciara Linnane

Moderna will hire 2,000 people and open new offices on the West Coast.

Mar. ET by Claudia Assis

Markets Retail Earnings Show Uncertain Outlook. The Fed needs consumers to cut back.

Mar. ET

Panel of FDA Panels from Biotech and Pharma Says Pfizer's RSV Vaccine is Safe and Effective

February 28, 2023, at 4:33 p.m. ET by Barron's

Biotech and Pharma Novavax say there is'substantial doubt' about its ability to continue operating this year

February 28, 2023, 4:02 p.m. ET by Barron's

Moderna Inc.

Moderna, Inc. is involved in the development and commercialization of transformative medicines that are based on messenger-ribonucleic acids (mRNA). Its product portfolio includes: prophylactic vaccinations, cancer vaccines and intratumoral immuno-oncology. Noubar B. Afeyan and Robert S. Langer Jr. founded the company. Derrick J. Rose and Kenneth R. Chien founded the company in Cambridge, MA in 2010.

Competitors

CureVac N.V. $1.44B -0.62%